209 |
Crossing the CTO - New Techniques and Technologies |
Jeffrey W. Moses |
Jun. 23. 06 |
208 |
Chronic Total Occlusions: Rationale for Recanalization, Patient Selection, and Results |
Barry D. Rutherford |
Jun. 23. 06 |
207 |
Systemic Therapy: Pharmacologic Approach or Cell/Gene Therapy |
Alan C. Yeung |
Jun. 16. 06 |
206 |
IVUS, Virtual Histology, Other Ultrasound Based Imaging Diagnostics |
Gary S. Mintz |
Jun. 16. 06 |
205 |
One Year Follow-Up of Plaque Rupture |
Myeong-Ki Hong |
Jun. 16. 06 |
204 |
MR Characterization of Atherosclerosis |
Chun Yuan |
Jun. 16. 06 |
203 |
Pathogenesis and Pathologic Features of Vulnerable Plaque |
Erling Falk |
Jun. 16. 06 |
202 |
Conor Erodable Polymer Paclitaxel Eluting Stent- Indian & European Experience |
Upendra Kaul |
Jun. 09. 06 |
201 |
Multivessel and Multilesion Stenting in Drug Eluting Era: Results from ERACI III Trial |
Alfredo Rodriguez |
Jun. 09. 06 |
200 |
BEACON Registry: An All-Comers Trial of Biolimus A9 Eluting Stent |
Tian-Hai Koh |
Jun. 09. 06 |